ImageneBio, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +315.8% | +95.9% | +47.2% | -30.5% | +11.5% | -26.3% | +8.1% | |
| – | +326.5% | +94.8% | +42.5% | -32.3% | +11.7% | -28.8% | +10.3% | |
| – | +352.1% | +98.0% | +42.9% | -74.2% | +100.1% | -67.1% | -11.2% | |
| – | +352.1% | +98.0% | +42.9% | -32.4% | +11.8% | -29.1% | -39.1% | |
| – | – | – | – | – | – | – | – | |
| – | +121.7% | +82.8% | -85.2% | -36.8% | -11.7% | -30.3% | +27.4% | |
| – | +535.4% | +16.6% | -4.0% | -20.9% | -33.9% | -24.1% | +4.2% | |
| – | – | – | +895.2% | +3.0% | +86.6% | +6.4% | -40.2% | |
| – | -58.8% | +127.0% | +12.3% | -12.2% | -1.3% | -56.6% | +60.4% | |
| – | – | – | – | -29.3% | +15.5% | -25.8% | +5.7% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.3% | +0.6% | +15.3% | -65.7% | +354.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.